Company Profile
Updated: 30-NOV-09Diosynth France S.A.
Non-Quoted Public Company
BP 26, Usine Saint Charles, Eragny sur Epte, F-60590, France
()33 02 32 15 89 94, 33 02 32 55 30 83 fax, http://www.merck.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Production of and wholesale trade in pharmaceuticals specialising in biologic therapeutics
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Biomanufacturing Strategies: Market Drivers, Build-vs-buy Decisions and Opportunities in Contract Relationship Management (CMO).
Business Wire; 11/13/2007; 2178 words; LYON, France -- Reportlinker.com announces that a...internalised or outsourced to partners or CMO's is increasingly crucial in the development...Bioreactor facilities Celltrion expansion Diosynth Diosynth's contract manufacturing deals Medium-sized...
Focus on the Imaging Agents Market - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals.
Business Wire; 8/28/2007; 1163 words; LYON, France -- Reportlinker.com...Japan 4. Europe 4a. France 4b. Germany 4c. The...Ltd. (Japan) 27. Diosynth Biotechnology (USA...36. Guerbet Group (France) 37. Hans O Mahn And...your Internet browser's address field. Remove...
Biotechnology company deals with other biotechnology companies: Feb. 22-April 19, 2007.(Statistical table)
Bioworld Financial Watch; 4/23/2007; 5661 words; ...opioid agonist BGC) (France) for the control of postoperative...Inc. (NSTK) DelSite's GelSite polymer for DelSite...immunoassay diagnostic products Diosynth Talecris Agreement for...Japan) Interprotein's interleukin-6 inhibitors...Galderma SA* Ipsen SA (France; Exclusive rights agreement...
European directive may be discouraging U.S. manufacturers from renovating API facilities, doing clinicals; assay validation costs higher?(International)
Validation Times; 6/1/2005; 1385 words; ...criticized the directive's requirement for assay...To date, Jones said, France, Luxembourg, the Netherlands...of QA and regulatory at Diosynth Biotechnology in Research...be submitted to. It's not standardized across...member countries." In France, we had to submit an...
Escalating Demand for Novel and Effective Therapeutic Approaches Underlines Growing Appeal of Peptides.
PR Newswire Europe; 1/12/2005; 1507 words; ...important markets included Scandinavia, France, Italy and Spain. Motivated by the development...being seen as a vindication of the market's strong growth potential. Globally, more...PolyPeptide Laboratories, Peptisyntha and Diosynth. All European manufactures confront escalating...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning